DENA
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
08/13/2026
Back to search
Official data from USPTO
GAXIMIS
This trademark appears in the official USPTO history.
Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILEDType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Case type
Application and registration
Recorded events
19
Latest update
08/13/2026
Trademark type
Word
Nice classes
5
Filing date
09/13/2019
Registration date
04/14/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/22/2026
Last transaction
08/13/2026
Responsible office
United States Patent and Trademark Office
Status code
404
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
CH
Examiner
DYER, ERIN ZASKODA
Law office
O30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
NOVARTIS AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publications
History of USPTO decisions and trademark events.
19 publications found
DETH
DEATH OF INTERNATIONAL REGISTRATION
08/13/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/14/2025
GPNX
NOTIFICATION PROCESSED BY IB
07/03/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/03/2020
FIMP
FINAL DISPOSITION PROCESSED
06/03/2020
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
05/14/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
04/14/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/28/2020
PUBO
PUBLISHED FOR OPPOSITION
01/28/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/08/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/19/2019
DOCK
ASSIGNED TO EXAMINER
12/13/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/12/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/12/2019
MAFR
APPLICATION FILING RECEIPT MAILED
11/19/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/14/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
11/12/2019
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
11/07/2019
Continuous trademark protection
Get notified about every new filing that threatens GAXIMIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.